glp 1 agonist brand name GLP-1 Receptor Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-Activate | Hunger & Metabolism

marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]

They found other small peptides that control insulin and appetite by acting on two or even three metabolic switches instead of just one

[DOI] [PubMed] [Google Scholar] 38.Sundby F., Jacobsen H., Moody A.J

Cardiovascular Diabetology, 13(1)

FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data

VIIH investigators in alphabetical order: Bsteh, Gabriel (Department of Neurology, Medical University of Vienna)